MedTrace Logo

Evaluating a Digital Peer Mentoring Platform With College Student Populations

NCT05764785 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2023-10-12

Study results available
· View outcomes & findings →

Summary

The goal of this clinical trial is to test the acceptability, feasibility, and efficacy of MentorPRO, a novel application that connects mentors and mentees, among incoming college first-year students in a public university. The main questions it aims to answer are:

* What is the acceptability and feasibility of the MentorPRO mentoring platform?
* Does mentoring with MentorPRO demonstrate an impact on academic outcomes (i.e., GPA) and indices of wellbeing (i.e., mental health, connectedness, academic self-efficacy, and overall wellbeing) among a diverse sample of incoming or first year college students?

Participants in the MentorPRO group will:

* Use MentorPRO with their assigned mentors to communicate for 9 weeks about transitioning to college and completing a brief summer course at the university
* Complete surveys about their opinions of MentorPRO

All participants (regardless of group assignment) will:

* Complete surveys about their mental health and overall wellbeing
* Work with a mentor throughout participation in a brief summer course at the university

Conditions

  • Well-Being, Psychological
  • Anxiety
  • Depression
  • Mentoring to Support the Transition to College

Interventions

BEHAVIORAL

MentorPRO

MentorPRO is a novel application and web platform for mentoring programs that allows students to set goals, track their challenges, and find just-in time resources, while connecting to a mentor for personalized support and progress monitoring.

Sponsors & Collaborators

  • University of Massachusetts, Boston

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Academic Web Pages

    lead INDUSTRY

Principal Investigators

  • Jean E Rhodes, PhD · University of Massachusetts, Boston

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-22
Primary Completion
2023-08-21
Completion
2023-08-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05764785 on ClinicalTrials.gov